全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
药学学报  2015 

法尼醇x受体与糖脂代谢

, PP. 245-251

Keywords: 法尼醇x受体,胆汁酸,葡萄糖,脂质,非酒精性脂肪肝

Full-Text   Cite this paper   Add to My Lib

Abstract:

法尼醇x受体(farnesoidxreceptor,fxr)属于核受体超家族,研究证明fxr可调控多种代谢通路,除在胆汁酸代谢中发挥重要作用外,fxr激活后参与维持机体糖脂代谢稳态。随着糖脂代谢异常相关疾病发病率的升高,fxr对糖脂代谢的调节越来越引起研究者的重视。fxr激动剂可能成为治疗2型糖尿病和脂代谢紊乱等代谢性疾病的新型药物靶点。

References

[1]  seolw,choihs,mooredd.isolationofproteinsthatinteractspecificallywiththeretinoidxreceptor:twonovelorphanreceptors[j].molendocrinol,1995,9:72-85.
[2]  formanbm,goodee,chenj,etal.identificationofanuclearreceptorthatisactivatedbyfarnesolmetabolites[j].cell,1995,81:687-693.
[3]  makishimam,okamotoay,repajj,etal.identificationofanuclearreceptorforbileacids[j].science,1999,284:1362-1365.
[4]  wangh,chenj,hollisterk,etal.endogenousbileacidsareligandsforthenuclearreceptorfxr/bar[j].molcell,1999,3:543-553.
[5]  düferm,hörthk,krippeit-drewsp,etal.thesignificanceofthenuclearfarnesoidxreceptor(fxr)inβcellfunction[j].islets,2012,4:333-338.
[6]  zhangy,kast-woelbernhr,edwardspa.naturalstructuralvariantsofthenuclearreceptorfarnesoidxreceptoraffecttranscriptionalactivation[j].jbiolchem,2003,278:104-110.
[7]  huberrm,murphyk,miaob,etal.generationofmultiplefarnesoid-x-receptorisoformsthroughtheuseofalternativepromoters[j].gene,2002,290:35-43.
[8]  leefy,leeh,hubbertml,etal.fxr,amultipurposenuclearreceptor[j].trendsbiochemsci,2006,31:572-580.
[9]  edwardspa,kasthr,anisfeldam.bareingitall:theadoptionoflxrandfxrandtheirrolesinlipidhomeostasis[j].jlipidres,2002,43:2-12.
[10]  kalaanyny,mangelsdorfdj.lxrsandfxr:theyinandyangofcholesterolandfatmetabolism[j].annurevphysiol,2006,68:159-191.
[11]  claudelt,sturme,duezh,etal.bileacid-activatednuclearreceptorfxrsuppressesapolipoproteina-itranscriptionviaanegativefxrresponseelement[j].jclininvest,2002,109:961-971.
[12]  goodwinb,jonessa,pricerr,etal.aregulatorycascadeofthenuclearreceptorsfxr,shp-1,andlrh-1repressesbileacidbiosynthesis[j].molcell,2000,6:517-526.
[13]  yangf,huangxf,yits,etal.spontaneousdevelopmentoflivertumorsintheabsenceofthebileacidreceptorfarnesoidxreceptor[j].cancerres,2007,67:863-867.
[14]  thomasc,pellicciarir,pruzanskim,etal.targetingbile-acidsignallingformetabolicdiseases[j].natrevdrugdiscov,2008,7:678-693.
[15]  kerrta,saekis,schneiderm,etal.lossofnuclearreceptorshpimpairsbutdoesnoteliminatenegativefeedbackregulationofbileacidsynthesis[j].devcell,2002,2:713-720.
[16]  wangl,leeyk,bundmand,etal.redundantpathwaysfornegativefeedbackregulationofbileacidproduction[j].devcell,2002,2:721-731.
[17]  holtja,luog,billinan,etal.definitionofanovelgrowthfactor-dependentsignalcascadeforthesuppressionofbileacidbiosynthesis[j].genesdev,2003,17:1581-1591.
[18]  inagakit,choim,moschettaa,etal.fibroblastgrowthfactor15functionsasanenterohepaticsignaltoregulatebileacidhomeostasis[j].cellmetab,2005,2:217-225.
[19]  modicas,petruzzellim,bellafantee,etal.selectiveactivationofnuclearbileacidreceptorfxrintheintestineprotectsmiceagainstcholestasis[j].gastroenterology,2012,142:355-365.
[20]  zhuy,lif,guogl.tissue-specificfunctionoffarnesoidxreceptorinliverandintestine[j].pharmacolres,2011,63:259-265.
[21]  yucd,wangf,kanm,etal.elevatedcholesterolmetabolismandbileacidsynthesisinmicelackingmembranetyrosinekinasereceptorfgfr4[j].jbiolchem,2000,275:15482-15489.
[22]  angelinb,einarssonk,hellströmk,etal.effectsofcholestyramineandchenodeoxycholicacidonthemetabolismofendogenoustriglycerideinhyperlipoproteinemia[j].jlipidres,1978,19:1017-1024.
[23]  hortonjd,goldsteinjl,brownms.srebps:activatorsofthecompleteprogramofcholesterolandfattyacidsynthesisintheliver[j].jclininvest,2002,109:1125-1131.
[24]  watanabem,houtensm,wangl,etal.bileacidslowertriglyceridelevelsviaapathwayinvolvingfxr,shp,andsrebp-1c[j].jclininvest,2004,113:1408-1418.
[25]  sirventa,claudelt,marting,etal.thefarnesoidxreceptorinducesverylowdensitylipoproteinreceptorgeneexpression[j].febslett,2004,566:173-177.
[26]  zhangy,castellanilw,sinalcj,etal.peroxisomeproliferator-activatedreceptor-γcoactivator1α(pgc-1α)regulatestriglyceridemetabolismbyactivationofthenuclearreceptorfxr[j].genesdev,2004,18:157-169.
[27]  fruchart-najibj,baugee,niculesculs,etal.mechanismoftriglycerideloweringinmiceexpressinghumanapolipoproteina5[j].biochembiophysrescommun,2004,319:397-404.
[28]  kasthr,nguyencm,sinalcj,etal.farnesoidx-activatedreceptorinducesapolipoproteinc-iitranscription:amolecularmechanismlinkingplasmatriglyceridelevelstobileacids[j].molendocrinol,2001,15:1720-1728.
[29]  claudelt,inouey,barbiero,etal.farnesoidxreceptoragonistssuppresshepaticapolipoproteinciiiexpression[j].gastroenterology,2003,125:544-555.
[30]  torraip,claudelt,duvalc,etal.bileacidsinducetheexpressionofthehumanperoxisomeproliferator-activatedreceptorαgeneviaactivationofthefarnesoidxreceptor[j].molendocrinol,2003,17:259-272.
[31]  lambertg,amarmj,guog,etal.thefarnesoidx-receptorisanessentialregulatorofcholesterolhomeostasis[j].jbiolchem,2003,278:2563-2570.
[32]  zhangy,leefy,barrerag,etal.activationofthenuclearreceptorfxrimproveshyperglycemiaandhyperlipidemiaindiabeticmice[j].procnatlacadsciusa,2006,103:1006-1011.
[33]  flattb,martinr,wangtl,etal.discoveryofxl335(way-362450),ahighlypotent,selective,andorallyactiveagonistofthefarnesoidxreceptor(fxr)[j].jmedchem,2009,52:904-907.
[34]  zhangyq,wangxp,valesc,etal.fxrdeficiencycausesreducedatherosclerosisinldlr-/-mice[j].arteriosclerthrombvascbiol,2006,26:2316-2321.
[35]  hannimanea,lambertg,mccarthytc,etal.lossoffunctionalfarnesoidxreceptorincreasesatheroscleroticlesionsinapolipoproteine-deficientmice[j].jlipidres,2005,46:2595-2604.
[36]  carioub,vanharmelenk,duran-sandovald,etal.thefarnesoidxreceptormodulatesadiposityandperipheralinsulinsensitivityinmice[j].jbiolchem,2006,281:11039-11049.
[37]  mak,sahapk,chanl,etal.farnesoidxreceptorisessentialfornormalglucosehomeostasis[j].jclininvest,2006,116:1102-1109.
[38]  yamagatak,daitokuh,shimamotoy,etal.bileacidsregulategluconeogenicgeneexpressionviasmallheterodimerpartner-mediatedrepressionofhepatocytenuclearfactor4andfoxo1[j].jbiolchem,2004,279:23158-23165.
[39]  stayrookkr,bramlettks,savkurrs,etal.regulationofcarbohydratemetabolismbythefarnesoidxreceptor[j].endocrinology,2005,146:984-991.
[40]  duran-sandovald,mautinog,marting,etal.glucoseregulatestheexpressionofthefarnesoidxreceptorinliver[j].diabetes,2004,53:890-898.
[41]  lutt,makishimam,repajj,etal.molecularbasisforfeedbackregulationofbileacidsynthesisbynuclearreceptors[j].molcell,2000,6:507-515.
[42]  gadaletarm,vanerpecumkj,oldenburgb,etal.farnesoidxreceptoractivationinhibitsinflammationandpreservestheintestinalbarrierininflammatoryboweldisease[j].gut,2011,60:463-472.
[43]  vavassorip,mencarellia,rengab,etal.thebileacidreceptorfxrisamodulatorofintestinalinnateimmunity[j].jimmunol,2009,183:6251-6261.
[44]  modicas,murzillis,salvatorel,etal.nuclearbileacidreceptorfxrprotectsagainstintestinaltumorigenesis[j].cancerres,2008,68:9589-9594.
[45]  lefebvrep,carioub,lienf,etal.roleofbileacidsandbileacidreceptorsinmetabolicregulation[j].physiolrev,2009,89:147-191.
[46]  moschettaa,bookoutal,mangelsdorfdj.preventionofcholesterolgallstonediseasebyfxragonistsinamousemodel[j].natmed,2004,10:1352-1358.
[47]  bouliask,katrakilin,bambergk,etal.regulationofhepaticmetabolicpathwaysbytheorphannuclearreceptorshp[j].emboj,2005,24:2624-2633.
[48]  wangl,liuj,sahap,etal.theorphannuclearreceptorshpregulatespgc-1αexpressionandenergyproductioninbrownadipocytes[j].cellmetab,2005,2:227-238.
[49]  matsukumake,bennettmk,huangjs,etal.coordinatedcontrolofbileacidsandlipogenesisthroughfxr-dependentregulationoffattyacidsynthase[j].jlipidres,2006,47:2754-2761.
[50]  fuchsm,ivandicb,müllero,etal.biliarycholesterolhypersecretioningallstone-susceptiblemiceisassociatedwithhepaticup-regulationofthehigh-densitylipoproteinreceptorsrbi[j].hepatology,2001,33:1451-1459.
[51]  zhaob,songjm,ghoshs.hepaticoverexpressionofcholesterylesterhydrolaseenhancescholesteroleliminationandinvivoreversecholesteroltransport[j].jlipidres,2008,49:2212-2217.
[52]  gautiert,dehaanw,groberj,etal.farnesoidxreceptoractivationincreasescholesterylestertransferproteinexpressioninhumansandtransgenicmice[j].jlipidres,2013,54:2195-2205.
[53]  hartmanhb,gardellsj,petuccicj,etal.activationoffarnesoidxreceptorpreventsatheroscleroticlesionformationinldlr-/-andapoe-/-mice[j].jlipidres,2009,50:1090-1100.
[54]  guogl,santamarina-fojos,akiyamate,etal.effectsoffxrinfoam-cellformationandatherosclerosisdevelopment[j].biochimbiophysacta,2006,1761:1401-1409.
[55]  carons,samanezch,dehondth,etal.farnesoidxreceptorinhibitsthetranscriptionalactivityofcarbohydrateresponseelementbindingproteininhumanhepatocytes[j].molcellbiol,2013,33:2202-2211.
[56]  inagakit,dutchakp,zhaog,etal.endocrineregulationofthefastingresponsebypparα-mediatedinductionoffibroblastgrowthfactor21[j].cellmetab,2007,5:415-425.
[57]  polstwh,noriegalg,nomuram,etal.thebileacidmembranereceptortgr5asanemergingtargetinmetabolismandinflammation[j].jhepatol,2011,54:1263-1272.
[58]  zhangy,leit,huangjf,etal.thelinkbetweenfibroblastgrowthfactor21andsterolregulatoryelementbindingprotein1cduringlipogenesisinhepatocytes[j].molcellendocrinol,2011,342:41-47.
[59]  liuxj,xuery,jill,etal.activationoffarnesoidxreceptor(fxr)protectsagainstfructose-inducedliversteatosisviainflammatoryinhibitionandadrpreduction[j].biochembiophysrescommun,2014,450:117-123.
[60]  zhangsw,wangj,liuqy,etal.farnesoidxreceptoragonistway-362450attenuatesliverinflammationandfibrosisinmurinemodelofnon-alcoholicsteatohepatitis[j].jhepatol,2009,51:380-388.
[61]  sinalcj,tohkinm,miyatam,etal.targeteddisruptionofthenuclearreceptorfxr/barimpairsbileacidandlipidhomeostasis[j].cell,2000,102:731-744.
[62]  wuwb,liuxj,pengxm,etal.bileacidsoverridesteatosisinfarnesoidxreceptordeficientmiceinamodelofnon-alcoholicsteatohepatitis[j].biochembiophysrescommun,2014,448:50-55.
[63]  duran-sandovald,carioub,percevaultf,etal.thefarnesoidxreceptormodulateshepaticcarbohydratemetabolismduringthefasting-refeedingtransition[j].jbiolchem,2005,280:29971-29979.
[64]  mudaliars,henryrr,sanyalaj,etal.efficacyandsafetyofthefarnesoidxreceptoragonistobeticholicacidinpatientswithtype2diabetesandnonalcoholicfattyliverdisease[j].gastroenterology,2013,145:574-582.
[65]  ghebremariamyt,yamadak,leejc,etal.fxragonistint-747upregulatesddahexpressionandenhancesinsulinsensitivityinhigh-saltfeddahlrats[j].plosone,2013,8:e60653.
[66]  popescuir,helleboid-chapmana,lucasa,etal.thenuclearreceptorfxrisexpressedinpancreaticβ-cellsandprotectshumanisletsfromlipotoxicity[j].febslett,2010,584:2845-2851.
[67]  rengab,mencarellia,vavassorip,etal.thebileacidsensorfxrregulatesinsulintranscriptionandsecretion[j].biochimbiophysacta,2010,1802:363-372.
[68]  jinlh,fengxh,rongh,etal.theantiparasiticdrugivermectinisanovelfxrligandthatregulatesmetabolism[j].natcommun,2013,4:1937.
[69]  gexm,yinly,mahy,etal.aldo-ketoreductase1b7isatargetgeneoffxrandregulateslipidandglucosehomeostasis[j].jlipidres,2011,52:1561-1568.
[70]  cyphertha,gexm,kohanab,etal.activationofthefarnesoidxreceptorinduceshepaticexpressionandsecretionoffibroblastgrowthfactor21[j].jbiolchem,2012,287:25123-25138.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133